4-Oxofenretinide
CAS No. 865536-65-8
4-Oxofenretinide( 4-Oxo-4-HPR | 4-Oxo Fenretinide | 4-Keto-4-HPR )
Catalog No. M17628 CAS No. 865536-65-8
4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 45 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 104 | In Stock |
|
| 25MG | 185 | In Stock |
|
| 50MG | 277 | In Stock |
|
| 100MG | 500 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-Oxofenretinide
-
NoteResearch use only, not for human use.
-
Brief Description4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis.
-
Description4-Oxo-4-HPR is an inhibitor of tubulin polymerization, inducing marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines. It is also a fenretinide metabolite.
-
In Vitro——
-
In Vivo——
-
Synonyms4-Oxo-4-HPR | 4-Oxo Fenretinide | 4-Keto-4-HPR
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
Recptorcell cycle arrest and apoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number865536-65-8
-
Formula Weight405.53
-
Molecular FormulaC26H31NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=C(C(CCC1=O)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)Nc1ccc(cc1)O)/C)/C
-
Chemical Name(2E,4E,6E,8E)-N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-3-oxocyclohexen-1-yl)nona-2,4,6,8-tetraenamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Villani MG,et al. Cancer Res. 2006 Mar 15;66(6):3238-47.
molnova catalog
related products
-
Secoxyloganin
Secoxyloganin possesses a hepato-protective effect. Secoxyloganin possesses antibacterial activity.
-
Carboprost trometham...
Carboprost tromethamine is the synthetic 15-methyl analogue of prostaglandin F2α and it can effectively promote law contraction of the uterus and significantly reduce the amount of bleeding during and after delivery.Carboprost tromethamine has been accounted for to be 84-96% successful in the treatment of persistent hemorrhage because of uterine atony.
-
TG6-129
TG6-129 is an antagonist of the EP2 receptor. TG6-129 suppresses PGE2-induced elevation of cAMP in cells expressing EP2 with an IC50 value of 1.6 μM.
Cart
sales@molnova.com